Gossamer Bio Inc
NASDAQ:GOSS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gossamer Bio Inc
NASDAQ:GOSS
|
US |
|
N
|
Nakayamafuku Co Ltd
TSE:7442
|
JP |
|
Ajanta Soya Ltd
BSE:519216
|
IN |
|
K
|
Kiatnakin Phatra Bank PCL
SET:KKP
|
TH |
|
Galata Wind Enerji Anonim Sirket
IST:GWIND.E
|
TR |
|
CapitaLand Integrated Commercial Trust
SGX:C38U
|
SG |
|
United Parcel Service Inc
NYSE:UPS
|
US |
|
Appfolio Inc
NASDAQ:APPF
|
US |
|
C
|
CIMC Vehicles Group Co Ltd
HKEX:1839
|
CN |
|
Planetel SpA
MIL:PLT
|
IT |
|
Comerica Inc
NYSE:CMA
|
US |
|
G
|
Golfzon Co Ltd
KOSDAQ:215000
|
KR |
|
S
|
Siam Food Products PCL
SET:SFP
|
TH |
|
V
|
Vertu Capital Ltd
LSE:VCBC
|
MY |
|
Cobalt Blue Holdings Ltd
ASX:COB
|
AU |
|
G
|
Greek Organisation of Football Prognostics SA
ATHEX:OPAP
|
GR |
|
K
|
Ke Holdings Inc
HKEX:2423
|
CN |
Profitability Summary
Gossamer Bio Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Gossamer Bio Inc
Margins Comparison
Gossamer Bio Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| US |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
85.3m USD |
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD |
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD |
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.5B EUR |
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Gossamer Bio Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
85.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
